Trends in Total Hip Arthroplasty in Spain (2001-2008)
Author Information
Author(s): Jimenez-García Rodrigo, Villanueva-Martínez Manuel, Fernandez-de-las-Penas Cesar, Hernandez-Barrera Valentín, Ríos-Luna Antonio, Garrido Pilar Carrasco, de Andres Ana Lopez, Jimenez-Trujillo Isabel, Montero Jesus San Roman, Gil-de-Miguel Angel
Primary Institution: Universidad Rey Juan Carlos, Madrid, Spain
Hypothesis
To analyze changes in incidence, comorbidity profile, length of hospital stay, costs, and in-hospital mortality of patients undergoing primary total hip arthroplasty in Spain over an 8-year period.
Conclusion
The study indicates an increased incidence of primary total hip arthroplasty in Spain from 2001 to 2008, with reductions in length of stay and slight reductions in in-hospital mortality, but a significant increase in costs per patient.
Supporting Evidence
- Overall crude incidence of THA increased from 99 to 105 per 100,000 inhabitants from 2001 to 2008.
- Mean length of hospital stay decreased from 13 days in 2001 to 10.45 days in 2008.
- Mean cost per patient increased from 6,634 Euros in 2001 to 9,474 Euros in 2008.
- Charlson comorbidity index showed an increase in patients with higher comorbidity scores over the study period.
- In-hospital mortality rate was 0.61% in 2008, with significant reductions observed among men.
Takeaway
More people in Spain are getting hip surgeries now than before, and while they spend less time in the hospital, the surgeries are costing more money.
Methodology
Analysis of surgical admissions for primary total hip arthroplasty from the National Hospital Discharge Database, using Poisson and logistic regression for statistical analysis.
Potential Biases
Potential bias from administrative coding and reliance on hospital discharge data.
Limitations
Relies on administrative data which may have discrepancies and does not include certain clinical variables.
Participant Demographics
Patients aged ≥40 years, with a majority being women (55%) and a significant number of patients having comorbidities.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 1.11-1.18
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website